Concurrent Plenary Sessions
John Lantos, MD
Director, Children's Mercy Bioethics Center, Children's Mercy Hospital; Professor of Pediatrics, University of Missouri at Kansas City
Children's Mercy Hospital
University of Missouri - Kansas City
Monica Mita, MD, MDSc
Professor of Medicine, Cedars-Sinai Medical Center; Professor of Medicine, University of California, Los Angeles; Co-Director, Experimental Therapeutics Program, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Hospital.
Avoiding therapeutic misconception in research has long been appreciated as an important concept — the premise being that research is not care. Distinguishing between research and care is important for subjects’ understanding of why they’re participating in research. While, historically, “therapeutic research/trials” have challenged these distinctions, there are now new challenges (e.g., the return of research results as a proposed benefit, novel cancer protocols that select human subjects based on the genetic footprint of their specific cancer, etc.). Is the boundary between research and clinical care eroding? Are subject expectations changing? Do researchers assume new responsibilities for providing or referring a subject to clinical care? What is the effect on recruitment strategies when there is promised benefit? What should be included in informed consent? These and other issues will be discussed during this panel.